Mil HIV Vac&Drug Dev
Abstract
This Project funds development of militarily relevant human immunodeficiency virus (HIV) medical countermeasures. It provides for the planning and conduct of human clinical trials in a group of healthy volunteers to assess for safety and tolerability of medical countermeasures, how the drug/vaccine is distributed through, metabolized in, and excreted from the body, and to investigate the appropriate dose. Development efforts are focused on militarily unique needs affecting manning, mobilization, and deployment. The cumulative cost of treating HIV-positive DoD personnel is estimated to be $16.6 billion for 3000 personnel over a 50-year lifetime. All clinical trials are conducted in accordance with U.S. FDA regulations. Products from this Project will transition to PE 0604807A/Project 812. Research efforts are coordinated with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases (NIAID), Division of Acquired Immune Deficiency Syndrome (DAIDS).
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2021
- Source ID
- 811_0603807A_4_2040_PB_2021
Related Documents
- Root: Medical Systems - Adv Dev
- Child Accomplishment: Military HIV Vaccine & Drug Development
- Child Accomplishment: FY 2020 SBIR/STTR Transfer
- Child Cost Item: ef8803754e0849239dd84ff08269f86c
- Child Cost Item: caf795458342f10fa422b31f10210ba4
- Child Cost Item: 3a7ae18bfbbe2732f0c128e43ddad944
- Child Cost Item: 24cedc9c8c462e880ada75f61993f906
- Child Cost Item: e5ba36b54d83c771b5b751a974d0f959
- Child Cost Item: efb6562dae18c5214c45db9dfac1fff9